Annual Total Debt
$298.98 M
+$224.31 M+300.39%
01 December 2023
Summary:
Sinovac Biotech annual total debt is currently $298.98 million, with the most recent change of +$224.31 million (+300.39%) on 01 December 2023. During the last 3 years, it has risen by +$162.60 million (+119.22%). SVA annual total debt is now at all-time high.SVA Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$324.51 M
+$25.52 M+8.54%
01 June 2024
Summary:
Sinovac Biotech quarterly total debt is currently $324.51 million, with the most recent change of +$25.52 million (+8.54%) on 01 June 2024. Over the past year, it has increased by +$25.52 million (+8.54%). SVA quarterly total debt is now at all-time high.SVA Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +8.5% |
| 3 y3 years | +119.2% | +85.9% |
| 5 y5 years | +2048.5% | +1624.7% |
SVA Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +300.4% | at high | +334.6% |
| 5 y | 5 years | at high | +2048.5% | at high | +1624.7% |
| alltime | all time | at high | at high |
Sinovac Biotech Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $324.51 M(+8.5%) |
| Dec 2023 | $298.98 M(+300.4%) | $298.98 M(+13.6%) |
| June 2023 | - | $263.19 M(+252.5%) |
| Dec 2022 | $74.67 M(-48.5%) | $74.67 M(-8.6%) |
| June 2022 | - | $81.72 M(-43.6%) |
| Dec 2021 | $144.91 M(+6.2%) | $144.91 M(-17.0%) |
| June 2021 | - | $174.58 M(+28.0%) |
| Dec 2020 | $136.39 M(+572.8%) | $136.39 M(+15.8%) |
| Sept 2020 | - | $117.76 M(+26.4%) |
| June 2020 | - | $93.13 M(+261.8%) |
| Mar 2020 | - | $25.74 M(+27.0%) |
| Dec 2019 | $20.27 M(+45.7%) | $20.27 M(+7.7%) |
| Sept 2019 | - | $18.82 M(-8.1%) |
| June 2019 | - | $20.46 M(-2.4%) |
| Mar 2019 | - | $20.98 M(+50.7%) |
| Dec 2018 | $13.92 M(-65.3%) | $13.92 M(>+9900.0%) |
| Sept 2018 | - | $0.00(-100.0%) |
| June 2018 | - | $29.45 M(>+9900.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $40.07 M(-6.9%) | $40.07 M(+9.8%) |
| June 2017 | - | $36.51 M(-15.2%) |
| Dec 2016 | $43.03 M(+72.1%) | $43.03 M(+13.9%) |
| Sept 2016 | - | $37.79 M(+29.5%) |
| June 2016 | - | $29.18 M(-18.8%) |
| Mar 2016 | - | $35.95 M(+43.8%) |
| Dec 2015 | $25.00 M(-51.7%) | $25.00 M(-11.5%) |
| Sept 2015 | - | $28.25 M(-19.8%) |
| June 2015 | - | $35.23 M(+6.3%) |
| Mar 2015 | - | $33.14 M(-36.0%) |
| Dec 2014 | $51.77 M(+0.2%) | $51.77 M(-12.1%) |
| Sept 2014 | - | $58.93 M(+15.9%) |
| June 2014 | - | $50.87 M(-5.1%) |
| Mar 2014 | - | $53.58 M(+3.7%) |
| Dec 2013 | $51.69 M(+37.0%) | $51.69 M(+5.8%) |
| Sept 2013 | - | $48.84 M(-0.2%) |
| June 2013 | - | $48.92 M(+8.2%) |
| Mar 2013 | - | $45.21 M(+19.8%) |
| Dec 2012 | $37.74 M | $37.74 M(+28.2%) |
| Sept 2012 | - | $29.44 M(+5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $28.05 M(+15.9%) |
| Mar 2012 | - | $24.20 M(+9.8%) |
| Dec 2011 | $22.03 M(+7.5%) | $22.03 M(-7.5%) |
| Sept 2011 | - | $23.82 M(+10.9%) |
| June 2011 | - | $21.48 M(+3.8%) |
| Mar 2011 | - | $20.69 M(+0.9%) |
| Dec 2010 | $20.49 M(+15.8%) | $20.49 M(+73.1%) |
| Sept 2010 | - | $11.84 M(+5.4%) |
| June 2010 | - | $11.24 M(-57.4%) |
| Mar 2010 | - | $26.37 M(+49.0%) |
| Dec 2009 | $17.70 M(+73.3%) | $17.70 M(-19.3%) |
| Sept 2009 | - | $21.94 M(-16.6%) |
| June 2009 | - | $26.30 M(+157.2%) |
| Mar 2009 | - | $10.23 M(+0.1%) |
| Dec 2008 | $10.21 M(-6.6%) | $10.21 M(+40.0%) |
| Sept 2008 | - | $7.29 M(-16.5%) |
| June 2008 | - | $8.73 M(-23.4%) |
| Mar 2008 | - | $11.39 M(+4.2%) |
| Dec 2007 | $10.94 M(+68.3%) | $10.94 M(+64.5%) |
| Sept 2007 | - | $6.65 M(+12.7%) |
| June 2007 | - | $5.90 M(>+9900.0%) |
| Mar 2007 | - | $0.00(-100.0%) |
| Dec 2006 | $6.50 M(+27.9%) | $6.50 M(>+9900.0%) |
| Sept 2006 | - | $0.00(-100.0%) |
| June 2006 | - | $5.70 M(>+9900.0%) |
| Mar 2006 | - | $0.00(-100.0%) |
| Dec 2005 | $5.08 M(+81.0%) | $5.08 M(>+9900.0%) |
| Sept 2005 | - | $0.00(-100.0%) |
| June 2005 | - | $2.80 M(>+9900.0%) |
| Mar 2005 | - | $0.00(-100.0%) |
| Dec 2004 | $2.81 M(+107.0%) | $2.81 M(+0.3%) |
| Sept 2004 | - | $2.80 M(+23.3%) |
| June 2004 | - | $2.27 M(>+9900.0%) |
| Mar 2004 | - | $0.00(-100.0%) |
| Dec 2003 | $1.36 M(>+9900.0%) | $1.36 M(>+9900.0%) |
| Sept 2003 | - | $0.00 |
| Apr 2002 | $2500.00(-98.6%) | - |
| Apr 2001 | $180.60 K(-63.7%) | - |
| Apr 2000 | $497.00 K(>+9900.0%) | - |
| Apr 1999 | $0.00 | - |
FAQ
- What is Sinovac Biotech annual total debt?
- What is the all time high annual total debt for Sinovac Biotech?
- What is Sinovac Biotech quarterly total debt?
- What is the all time high quarterly total debt for Sinovac Biotech?
- What is Sinovac Biotech quarterly total debt year-on-year change?
What is Sinovac Biotech annual total debt?
The current annual total debt of SVA is $298.98 M
What is the all time high annual total debt for Sinovac Biotech?
Sinovac Biotech all-time high annual total debt is $298.98 M
What is Sinovac Biotech quarterly total debt?
The current quarterly total debt of SVA is $324.51 M
What is the all time high quarterly total debt for Sinovac Biotech?
Sinovac Biotech all-time high quarterly total debt is $324.51 M
What is Sinovac Biotech quarterly total debt year-on-year change?
Over the past year, SVA quarterly total debt has changed by +$25.52 M (+8.54%)